HDAC10 Inhibits Cervical Cancer Progression through Downregulating the HDAC10-microRNA-223-EPB41L3 Axis.
Yuan Yuan GuGuan Nan ZhouYao LiHong Yu HeJing-Xin DingKe-Qin HuaPublished in: Journal of oncology (2022)
The study clarifies that HDAC10 inhibits cervical cancer by downregulating miR-223 and subsequently targeting EPB41L3 expression, which might provide a new insight for management upon cervical cancer and precancer lesions.